Skip to main content
Figure 2 | Cell Division

Figure 2

From: FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients

Figure 2

FISH using a FBXW 7 specific probe to detect allelic loss. (A) Specificity of the RP11-300I24 probe containing FBXW 7 on metaphase chromosomes from normal lymphocytes. The probe is labeled with SpectrumRed. (B-D) Dual color FISH patterns of nuclei from frozen touch prints of human glioblastoma. The 4q31.3 probe is labeled green and the CEN4 probe is labeled red. (B) normal signal, (C) monosomic for chromosome 4, (D) monoallelic deletion of 4q31.3. The table summarizes the results drawn from the FISH analysis for tumors with FBXW7 downregulation and 4q31.3 deletion (samples 3–10). Samples 1 and 2 are from tumors with no significant downregulation of FBXW 7 expression. Control tissues were from reactive lymphadenitis. Using 10% as a cut-off value, 18/26 tumors with significant downregulation of FBXW 7 are classified as not deleted (not detailed in the table).

Back to article page